Blockchain Registration Transaction Record

SeaStar Medical Receives Six FDA Breakthrough Device Designations for Innovative Medical Devices

SeaStar Medical achieves significant milestone with six FDA Breakthrough Device Designations, showcasing their cutting-edge technology and potential to transform treatments for critically ill patients. Learn how their innovative Selective Cytopheretic Device therapy targets hyperinflammatory cells to restore immune balance and improve outcomes.

This news matters as SeaStar Medical's groundbreaking technology has the potential to revolutionize treatments for critically ill patients, offering hope for better outcomes and improved survival rates. With the FDA's Breakthrough Device Designations, SeaStar's innovative solutions could lead to faster approvals and increased access to life-saving medical devices.